It has been demonstrated that Psap−/− mice develop inflammation, plaque formation and show a reduction of oxidative phosphorylation thus pointing out Psap as a potential therapeutic target for atherosclerosis (van Leent et al., 2021). This evidence concerns the gene PSAP and atherosclerosis.